Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Over the past 3 months, 7 analysts have published their opinion on Etsy (NASDAQ:ETSY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Where TPG Stands With Analysts

Analysts have provided the following ratings for TPG (NASDAQ:TPG) within the last quarter:

Benzinga

Sony's New Gaming Subscription PlayStation Plus Vs. Microsoft Game Pass - How Analysts View It

Sony Group (NYSE:SONY) bundled its existing PlayStation Plus and PlayStation Now services into one single subscription service called PlayStation Plus. Sony's move seems to pit it against Microsoft Corp's (NASDAQ:MSFT) Xbox Game Pass game subscription service, Reuters reports. The revamped Sony service combines the current PlayStation Plus, which has 48 million subscribers, with PlayStation Now, which…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Hallador Energy's Return On Capital Employed Insights

Hallador Energy (NASDAQ:HNRG) brought in sales totaling $65.51 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 196.97%, resulting in a loss of $7.74 million.

Benzinga

Ayala Pharmaceuticals's Return On Capital Employed Overview

Benzinga Pro data, Ayala Pharmaceuticals (NASDAQ:AYLA) reported Q4 sales of $1.15 million. Earnings fell to a loss of $10.05 million, resulting in a 2.58% decrease from last quarter.

Benzinga

Looking Into 4D Molecular Therapeutics's Return On Capital Employed

Benzinga Pro data, 4D Molecular Therapeutics (NASDAQ:FDMT) reported Q4 sales of $92.00 thousand. Earnings fell to a loss of $25.08 million, resulting in a 12.79% decrease from last quarter.

Benzinga

SWK Holdings's Return On Capital Employed Insights

According to Benzinga Pro, during Q4, SWK Holdings (NASDAQ:SWKH) earned $6.33 million, a 182.08% increase from the preceding quarter. SWK Holdings also posted a total of $14.96 million in sales, a 56.44% increase since Q3.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Aveanna Healthcare Hldgs's Return On Capital Employed Overview

Aveanna Healthcare Hldgs (NASDAQ:AVAH) brought in sales totaling $414.07 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 6137.89%, resulting in a loss of $126.19 million.

Benzinga

Progenity Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Progenity (NASDAQ:PROG) reported Q4 sales of $435.00 thousand. Earnings fell to a loss of $92.87 million, resulting in a 112.31% decrease from last quarter.

Benzinga

Looking Into Trxade Group's Return On Capital Employed

According to data from Benzinga Pro, during Q4, Trxade Group's (NASDAQ:MEDS) reported sales totaled $2.40 million. Despite a 39.75% increase in earnings, the company posted a loss of $784.34 thousand.

Benzinga

Looking Into ThermoGenesis Holdings's Return On Capital Employed

ThermoGenesis Holdings (NASDAQ:THMO) brought in sales totaling $2.42 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 61.05%, resulting in a loss of $2.89 million.

Benzinga

AEye's Return On Capital Employed Overview

AEye (NASDAQ:LIDR) brought in sales totaling $416.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 43.93%, resulting in a loss of $25.03 million.

Benzinga

Looking Into Fortress Biotech's Return On Capital Employed

Benzinga Pro data, Fortress Biotech (NASDAQ:FBIO) reported Q4 sales of $18.28 million. Earnings fell to a loss of $68.51 million, resulting in a 49.38% decrease from last quarter.

Benzinga

CASI Pharmaceuticals's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q4, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $9.16 million. Despite a 46.15% increase in earnings, the company posted a loss of $5.39 million.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Venus Concept Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q4, Venus Concept's (NASDAQ:VERO) reported sales totaled $32.63 million. Despite a 53.5% increase in earnings, the company posted a loss of $4.11 million.

Benzinga

Looking Into Tango Therapeutics's Return On Invested Capital

Benzinga Pro data, Tango Therapeutics (NASDAQ:TNGX) reported Q4 sales of $5.72 million. Earnings fell to a loss of $22.05 million, resulting in a 12.54% decrease from last quarter.

Benzinga

Checkpoint Therapeutics's Return On Capital Employed Insights

Checkpoint Therapeutics (NASDAQ:CKPT) brought in sales totaling $16.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 164.15%, resulting in a loss of $29.76 million.

Benzinga

Verastem Oncology's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q4, Verastem Oncology's (NASDAQ:VSTM) reported sales totaled $545.00 thousand. Despite a 27.67% increase in earnings, the company posted a loss of $16.48 million.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why NeoGenomics Stock Is Plunging Today

NeoGenomics Inc's (NASDAQ:NEO) CEO Mark Mallon will step down as CEO and member of the Board, effective immediately. The Board has retained Russell Reynolds to search for the Company's next CEO The Board has appointed current Chair Lynn Tetrault, Esq. as Executive Chair and established an Interim Office of the CEO. Read…

Benzinga

Read How EHang Holdings Fared In Q4

EHang Holdings Ltd (NASDAQ:EH) reported fourth-quarter FY21 revenues of RMB8.7 million ($1.4 million), compared with RMB13 million in 3Q21 and RMB54.6 million in 4Q20. The gross margin was 60.1%, compared with 61.8% in Q3. The decrease reflects changes in the revenue mix. Adjusted loss per ADS was $(0.22) or RMB(1.46) compared to…

Benzinga

Tigress Financial Analyst Sees 45% Upside In Nvidia - Read Why

Tigress Financial analyst Ivan Feinseth raised the price target on NVIDIA Corp (NASDAQ:NVDA) to $410 from $400 and kept a Buy rating. The price target implied an upside of 45.3%. Nvidia's recent analyst day and GPU Technology Conference, or GTC, highlighted new products and their advancement in AI, further powering data centers, gaming,…

Benzinga

Benzinga's Daily Brief On Trending Tickers For March 29, 2022: GameStop, Tesla, OIL ETF And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

Benzinga

Researchers Accuse Russia's Yandex Of Breach Of User Privacy

Researchers alleged that Russian internet company Yandex NV (NASDAQ:YNDX) had embedded code into apps found on mobile devices that help to transmit user information to Russian servers, the Financial Times reports. Yandex's software helped developers create apps for devices running Apple Inc's (NASDAQ:AAPL) iOS and Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google's Android, systems that ran the vast majority…

Benzinga

Here's How Analysts View Apple's Latest Products, Services

Analysts tried to gauge the impact of Apple Inc's (NASDAQ:AAPL) products and services. Apple is exploring subscription offerings for its hardware products as early as late 2022 or 2023. Morgan Stanley analyst Katy Huberty saw that the average Apple user spent $280 on hardware and added $69 to Apple Services revenue in 2021, implying, Apple…

Benzinga

10 Biggest Price Target Changes For Tuesday

BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.

1 … 785 786 787 788

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.